MRAI OTC
Marpai, Inc.
1W: +8.5%
1M: +38.3%
3M: +390.0%
YTD: +411.9%
1Y: +150.4%
3Y: +417.4%
$3.43
+0.13 (+4.07%)
Weekly Expected Move ±17.5%
$2
$3
$3
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
21 relationships21
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-08-09
Earliest Filing
2025-10-06
Latest Filing
investor: 7
partner: 7
acquirer: 4
target: 3
Counterparties (Filed by MRAI)
21 relationshipsCompanies named in MRAI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| HillCour Investment Fund, LLC | — | investor | Private placement investor purchasing 147,058 shares of Class A common stock at $1.36 per share. | 2025-10-06 | View |
| HillCour Investment Fund, LLC | — | investor | Purchased 896,903 shares of Class A common stock in a private placement. | 2025-09-16 | View |
| HillCour Investment Fund, LLC | — | investor | Purchased 371,470 shares of Class A common stock in a private placement. | 2025-08-04 | View |
| AXA S.A. | — | acquirer | Counterparty in Membership Interest Purchase Agreement and Debt Reduction Agreement regarding acquisition of Maestro Hea | 2025-02-06 | View |
| HillCour Investment Fund, LLC | — | investor | Purchased 910,000 shares of Marpai Inc. Class A common stock in a private placement. | 2024-03-08 | View |
| AXA S.A. | — | investor | Counterparty in Amendment No. 1 to Purchase Agreement regarding Maestro Health, LLC membership interests. | 2024-02-08 | View |
| Libertas Funding LLC | — | investor | Counterparty in Agreement of Sale of Future Receipts purchasing future receipts from Marpai, Inc. | 2024-02-08 | View |
| HillCour Investment Fund, LLC | — | investor | Purchased 150,000 shares of Class A common stock in a private placement. | 2023-12-15 | View |
| Payflex Systems USA, Inc. | — | acquirer | Acquired certain assets relating to Marpai's consumer directed benefits business. | 2023-12-15 | View |
| ThinkEquity LLC | — | partner | Underwriter representative for the public offering of Class A common stock | 2023-04-19 | View |
| Maestro Health, LLC | — | target | Target company acquired by Marpai, Inc. in a business combination. | 2023-01-10 | View |
| X.L. America, Inc. | — | partner | Signatory to the Membership Interest Purchase Agreement for the acquisition. | 2023-01-10 | View |
| Seaview Re Holdings Inc. | — | partner | Signatory to the Membership Interest Purchase Agreement for the acquisition. | 2023-01-10 | View |
| AXA S.A. | — | partner | Signatory to the Membership Interest Purchase Agreement and parent of Maestro Health. | 2023-01-10 | View |
| Maestro Health, LLC | — | target | Target company acquired by Marpai, Inc. in a deal to expand AI-powered health services and pharmacy cost containment. | 2022-11-01 | View |
| X.L. America, Inc. | — | partner | Delaware corporation that executed the Membership Interest Purchase Agreement for the acquisition. | 2022-11-01 | View |
| Seaview Re Holdings Inc. | — | partner | Delaware corporation that executed the Membership Interest Purchase Agreement for the acquisition. | 2022-11-01 | View |
| AXA S.A. | — | partner | French société anonyme that executed the Membership Interest Purchase Agreement for the acquisition. | 2022-11-01 | View |
| XL America Inc. | — | acquirer | Seller of equity interests in Maestro Health, LLC | 2022-08-09 | View |
| Seaview Re Holdings Inc. | — | acquirer | Seller of equity interests in Maestro Health, LLC | 2022-08-09 | View |
| Maestro Health, LLC | — | target | Target company acquired by Marpai, Inc. | 2022-08-09 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-31 | Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Other Events; Exhibits | Agreement | View |
| 2026-07-20 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-05-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-03-11 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2026-02-13 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2026-01-23 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-11-12 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-20 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-10-06 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-09-16 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-08-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-27 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-04 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-07-21 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-13 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-03-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR